Gly (μm) | τ1 (ms) | τ2 (ms) | τ3 (ms) | Mean open time (ms) |
---|---|---|---|---|
(n) | Area (%) | Area (%) | Area (%) | |
10 | 0.13 ± 0.05 | 0.5 ± 0.1 | 1.5 ± 0.1 | 0.7 ± 0.1 |
(4) | (18 ± 8%) | (60 ± 7%) | (22 ± 2%) | |
50 | — | 0.4 ± 0.1 | 1.5 ± 0.2 | 1.0 ± 0.1 |
(5) | (50 ± 1%) | (50 ± 1%) | ||
100 | — | 0.5 ± 0.1 | 2.1 ± 0.4 | 1.3 ± 0.2 |
(6) | (51 ± 6%) | (49 ± 5%) | ||
200 | — | 0.4 ± 0.1 | 2.0 ± 0.1 | 1.5 ± 0.1 |
(2) | (24 ± 6%) | (76 ± 7%) | ||
500 | — | 0.4 ± 0.1 | 2.8 ± 1.0 | 1.7 ± 0.1 |
(4) | (15 ± 4%) | (85 ± 4%) | ||
1000 | — | — | 2.7 ± 0.2 | 2.7 ± 0.2 |
(5) | (100%) |
Distribution of open periods was fitted with mixtures of exponential components. The exponential time constant of each component and its relative area (in parentheses) are given as mean ± SD of the mean. Note the increase in the area of the slowest component with increasing concentration of agonist.